Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
optimizerx分析师评级的重要见解：你需要知道的
7 analysts have shared their evaluations of OptimizeRx (NASDAQ:OPRX) during the recent three months, expressing a mix of bullish and bearish perspectives.
在过去的三个月中，有7位分析师分享了对optimizerx (纳斯达克:OPRX) 的评价，表达了对看涨和看跌的不同观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.0, a high estimate of $17.00, and a low estimate of $13.00. Surpassing the previous average price target of $14.25, the current average has increased by 5.26%.
分析师评估的12个月价格目标揭示了更多的见解，其中包括平均目标价为15.0美元，最高估计为17.00美元，最低估计为13.00美元。超过了之前的平均目标价14.25美元，目前的平均目标价增加了5.26%。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
An in-depth analysis of recent analyst actions unveils...
近期分析师行动的深...
登录免费看全文
登录/注册